These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 5134893

  • 1. Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
    Spark RF, Melby JC.
    Ann Intern Med; 1971 Dec; 75(6):831-6. PubMed ID: 5134893
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
    Beevers DG, Brown JJ, Ferriss JB, Fraser R, Lever AF, Robertson JI.
    Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
    [No Abstract] [Full Text] [Related]

  • 4. Dexamethasone-responsive hypertension in young women with suppressed renin and aldosterone.
    Hoefnagels WH, Drayer JI, Hofman JA, Kloppenborg PW, Smals AG, Benraad TJ.
    Lancet; 1978 Apr 08; 1(8067):741-3. PubMed ID: 76749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.
    Hoffbrand BI, Edmonds CJ, Smith T.
    Br Med J; 1976 Mar 20; 1(6011):682-4. PubMed ID: 766908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN, Zweifler AJ, Hansson L, Schork MA, Ellis C.
    Aust N Z J Med; 1975 Feb 20; 5(1):17-24. PubMed ID: 1057909
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.
    Karppanen H, Lahovaara S, Männistö P, Vapaatalo H.
    Acta Physiol Scand; 1975 Jun 20; 94(2):184-8. PubMed ID: 168735
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI.
    Clin Endocrinol (Oxf); 1987 Jul 20; 27(1):49-62. PubMed ID: 2820623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M, Brown RD.
    J Clin Invest; 1978 Jun 20; 61(6):1456-62. PubMed ID: 659608
    [Abstract] [Full Text] [Related]

  • 20. Genetics of the mineralocorticoid system in primary hypertension.
    Ferrari P.
    Curr Hypertens Rep; 2002 Feb 20; 4(1):18-24. PubMed ID: 11790287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.